West Roxbury, MA, United States of America

Angela L Woods

This inventor holds 1 USPTO granted patent. Top assignee: Avant Immunotherapeutics, Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angela L Woods. Retrieved from https://idiyas.com/inventor/angela-l-woods

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angela L Woods: Innovator in Immunoadjuvant Technology

Introduction

Angela L Woods is a prominent inventor based in West Roxbury, MA (US). She has made significant contributions to the field of immunology through her innovative work on polyphosphazene microspheres. Her research focuses on developing soluble polyphosphazene polyelectrolyte immunoadjuvants, which have the potential to enhance vaccine efficacy.

Latest Patents

Angela holds 1 patent for her invention titled "Polyphosphazene microspheres." This patent discloses a soluble polyphosphazene polyelectrolyte immunoadjuvant. In one embodiment, the polymeric adjuvant is poly[di(carboxylatrophenoxy)phosphazene], which is formed into microspheres and adsorbed with antigen after the microsphere formation. Notably, this immunoadjuvant can be administered intranasally, offering a novel approach to vaccine delivery.

Career Highlights

Angela is associated with Avant Immunotherapeutics, Inc., where she continues to advance her research in immunotherapy. Her work is pivotal in developing new strategies for enhancing immune responses, particularly in vaccine applications.

Collaborations

Angela collaborates with notable colleagues, including Lendon G Payne and Sharon A Jenkins. Their combined expertise contributes to the innovative research environment at Avant Immunotherapeutics, Inc.

Conclusion

Angela L Woods is a trailblazer in the field of immunoadjuvant technology, with her innovative patent paving the way for advancements in vaccine delivery systems. Her contributions are vital to the ongoing development of effective immunotherapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…